Tranzyme, Inc. (TZYM) Reports In-Line Q1 Loss of 34c/Share
Tweet Send to a FriendGet Alerts TZYM Hot Sheet
Trade TZYM Now!
Tranzyme, Inc. (NASDAQ: TZYM) reported Q1 EPS of ($0.34), in-line with the analyst estimate of ($0.34). Revenue for the quarter came in at $2.61 million versus the consensus estimate of $2.37 million.
For earnings history and earnings-related data on Tranzyme, Inc. (TZYM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Tranzyme, Inc. (TZYM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Destination Xl Grp (DXLG) Tops Q1 EPS by 1c; Comps Up 17.7%
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
